Abbott India Ltd Share Price (ABBOTINDIA)

Sun Pharma, Abbott India and Torrent Pharma Lose Most Share - 17 Nov, 2023

Abbott India Ltd is among the companies that lost the most share during the period.

Abbott India Q2 2024 Results Show Revenue Growth of 8.3% - 14 Nov, 2023

Abbott India Ltd reported revenue of ₹14.9b in Q2 2024, up 8.3% YoY, with net income of ₹3.13b, up 18%. The profit margin increased to 21%, driven by higher revenue. EPS was ₹147. Abbott India's revenue is forecasted to grow at a rate of 12% p.a.

Abbott India Shares Fall Despite Strong Q2 Results - 13 Nov, 2023

Abbott India reported a 17% YoY increase in Q2FY24 net profit, but shares fell by almost 3%. CLSA downgraded the stock to overweight and raised its target price.

General Public Holds 16% Ownership in Abbott India - 06 Oct, 2023

Public companies own 75% of Abbott India stock, while the general public holds a 16% ownership. This group can have a real influence on how the company is run.

Abbott India Warns of Supply Shortages for Laxative Syrups - 25 Sep, 2023

Abbott India Ltd has warned of potential supply shortages for two popular laxative syrups after production was prohibited in Goa state.

Abbott India Reports Growth in Financials - 21 Sep, 2023

Abbott India Ltd has reported growth in revenue, net profits, and net margins over the last few FYs. The company also has a low debt to equity ratio of 0.00.

Abbott India Faces Manufacturing Issues in Goa Plant - 15 Sep, 2023

Abbott India faces manufacturing issues at its Goa plant, leading to a recall of Digene Gel. The stock initially dipped but later recovered on news of corrective measures.

Goa State Plans to Suspend Abbott India's Manufacturing License - 14 Sep, 2023

Abbott India faces suspension of its manufacturing license for antacid medicine due to contamination risks and sanitization issues at its Goa factory.

Abbott India Recalls Antacid Due to Safety Concerns - 06 Sep, 2023

Abbott India has recalled several batches of antacid Digene Gel after the Drug Controller General of India (DCGI) issued an advisory against using the product. The impugned product may be unsafe and could result in adverse effects when consumed.

Abbott India's Share Price Soars and Gains Market Share - 14 Aug, 2023

Abbott India Ltd's share price has seen significant growth over the past five years, with a TSR of 220%, while also gaining maximum share in the Indian pharma market.

Redcliffe Labs Collaborates with Abbott India to Introduce Clinical Decision Support - 13 Aug, 2023

Abbott India has partnered with Redcliffe Labs to introduce clinical decision support (CDS) powered by Big Data Engines and AI, aimed at enhancing patient care and convenience.

Abbott India's Q2 Revenue Grows by 6% - 11 Aug, 2023

India contributed 38% of Abbott India's total revenue for the quarter, with a 6% growth in revenue. Sales of active pharmaceutical ingredients rose 14%. Research and development investments stood at Rs 324 crore.

Abbott India Reports Strong Q1 Results - 10 Aug, 2023

Abbott India Ltd's net profit for Q1 FY23 rose 41.2% YoY to Rs 290.20 crore, aided by a 13.4% increase in revenue and improved EBITDA margin.

Abbott India Reports Strong Q1 Results - 09 Aug, 2023

Abbott India Ltd reports a strong Q1 FY24 with a 41.2% YoY increase in net profit and approval of new Company Secretary and Compliance Officer.

Abbott India Hits New High Amidst Fake Medicine Scandal - 04 Aug, 2023

Abbott India Ltd's stock hit a new 52-week high of Rs 24,682.45 amidst the seizure of fake medicines of many leading pharma companies including Abbott.

Abbott India Stock Reaches All-Time High - 03 Aug, 2023

Abbott India's stock price reached an all-time high of Rs 24,613.25 on August 3.

Abbott India Ltd to Trade Ex-Dividend on July 21, 2023 - 16 Jul, 2023

Abbott India Ltd is set to trade ex-dividend on July 21, 2023. The company's next dividend payment will be ₹325 per share, which represents a trailing yield of 1.4% on the current share price of ₹23293.9. Abbott India's payout ratio is modest, at just 40% of profit, and the dividend is covered by both profits and cash flow, suggesting that it is sustainable.

Abbott India to Increase Dividend Payment - 15 Jul, 2023

Abbott India Ltd will increase its dividend payment to Rs 325.00, with a sustained record of paying dividends and growing EPS at 19% per year over the past five years.

Abbott India Ltd to Hold Its 79th AGM Virtually - 14 Jul, 2023

Abbott India Ltd will conduct its 79th Annual General Meeting virtually on August 9, 2023, covering the adoption of audited financial statements, declaration of dividends, appointment of directors, and ratification of remuneration payable to cost auditors.

Abbott India Ltd to Increase Dividend Payment - 01 Jul, 2023

Abbott India Limited plans to increase its dividend payment to ₹325.00, taking the annual payment to 1.4% of the stock price, which is above what most companies in the industry pay. The company has a sustained record of paying dividends with very little fluctuation.